Amneal Pharmaceuticals (AMRX) Equity Ratio (2017 - 2025)
Historic Equity Ratio for Amneal Pharmaceuticals (AMRX) over the last 9 years, with Q3 2025 value amounting to 0.03.
- Amneal Pharmaceuticals' Equity Ratio fell 1298.06% to 0.03 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.03, marking a year-over-year decrease of 1298.06%. This contributed to the annual value of 0.03 for FY2024, which is 64274.58% down from last year.
- Latest data reveals that Amneal Pharmaceuticals reported Equity Ratio of 0.03 as of Q3 2025, which was down 1298.06% from 0.03 recorded in Q2 2025.
- Amneal Pharmaceuticals' Equity Ratio's 5-year high stood at 0.1 during Q1 2022, with a 5-year trough of 0.04 in Q1 2025.
- In the last 5 years, Amneal Pharmaceuticals' Equity Ratio had a median value of 0.04 in 2023 and averaged 0.03.
- Per our database at Business Quant, Amneal Pharmaceuticals' Equity Ratio soared by 1312.97% in 2022 and then tumbled by 64274.58% in 2024.
- Amneal Pharmaceuticals' Equity Ratio (Quarter) stood at 0.09 in 2021, then crashed by 48.01% to 0.05 in 2022, then plummeted by 88.1% to 0.01 in 2023, then plummeted by 642.75% to 0.03 in 2024, then rose by 2.34% to 0.03 in 2025.
- Its Equity Ratio stands at 0.03 for Q3 2025, versus 0.03 for Q2 2025 and 0.04 for Q1 2025.